Table 1.
Recent patents in Nrf2-ARE pathway activators for treatment of central nervous system disorders.
| S.No | Patent | Application Number | Title | Applicant | PubDate |
|---|---|---|---|---|---|
| 1 | WO/2011/156889 | PCT/CA2011/000649 | NOVEL MODULATORS OF NRF2 AND USES THEREOF | TRT Pharma Inc. | 12/22/11 |
| 2 | WO/2010/107733 | PCT/US2010/027394 | TREATMENT OF NUCLEAR FACTOR (ERYTHROID- DERIVED 2)-LIKE 2 (NRF2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO NRF2 |
OPKO CURNA, LLC. |
9/23/10 |
| 3 | WO/2010/036711 | PCT/US2009/058050 | METHODS OF MODULATING PROTEIN HOMEOSTASIS, METABOLIC SYNDROME, HEAVY METAL INTOXICATION AND NRF2 TRANSCRIPTION FACTORS |
Bach Pharma Inc. | 4/1/10 |
| 4 | WO/2009/036204 | PCT/US2008/076064 | PHASE II DETOXIFICATION AND ANTIOXIDANT ACTIVITY |
Joslin Diabetes center Inc. |
3/19/09 |
| 5 | WO/2008/136838 | PCT/US2007/071933 | NOVEL AMIDE DERIVATIVES OF CDDO AND METHODS OF USE THEREOF |
Trustees of Dartmouth College |
11/13/08 |
| 6 | WO/2008/108825 | PCT/US2007/021748 | NEUROPROTECTIVE COMPOSITIONS AND METHODS | Burnham Institute for medical research |
9/12/08 |
| 7 | WO/2007/008652 | PCT/US2006/026503 | METHODS AND COMPOSITIONS DIRECTED TO DJ-1 AS REGULATOR OF THE ANTI-OXIDANT TRANSCRIPTION FACTOR NRF2 |
the University of North Carolina at Chapel Hill |
1/18/07 |
| 8 | WO/2007/005879 | PCT/US2006/026056 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATING TO OXIDATIVE STRESS |
The Johns Hopkins University |
1/11/07 |
| 9 | WO/2008/097596 | PCT/US2008/001602 | NRF2 SCREENING ASSAYS AND RELATED METHODS AND COMPOSITIONS |
Biogen Idec Inc. | 8/14/08 |